10-Year knee study tests if new treatment outlasts surgery
NCT ID NCT06916728
First seen Jun 27, 2026 · Last updated Jul 17, 2026 · Updated 2 times
Summary
This study follows 170 people for 10 years to see if a marketed product (MP01) works better than standard knee surgery for joint surface lesions. Participants had already been in an earlier trial. Researchers will measure knee pain, function, and quality of life, and track any additional procedures needed. The goal is to confirm long-term benefits and safety.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for JOINT SURFACE KNEE LESIONS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
AZ Monica
Antwerp, 2018, Belgium
-
County Hospital Timis Othopedy and Trauma Clinic II
Timișoara, 300736, Romania
-
Hadassah Medical Center
Jerusalem, 9103401, Israel
-
Horizon Clinical Research
La Mesa, California, 91942-3026, United States
-
Humanitas Gavazzeni
Bergamo, 24125, Italy
-
Institut za Ortopedsko hiruske Bolesti "Banjica"
Belgrade, 11000, Serbia
-
Istituto Clinico Humanitas
Milan, 20089, Italy
-
Klinika Orto MD
Novi Sad, 21000, Serbia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Muscle biofeedback may speed knee recovery — a trial puts it to the test
- Which tendon graft helps female athletes recover best after ACL surgery?
- Knee surgery showdown: button vs. screw for ACL graft fixation
- Light exercise with a blood pressure cuff may rebuild leg muscle after knee replacement
- Walking retraining after ACL injury may stave off knee arthritis
- Could a Cannabis-Derived drug replace opioids after knee surgery?